The second messenger concept and lipid metabolism.
D000227:Adenine Nucleotides / Q000502:physiology*; D000255:Adenosine Triphosphate / Q000502:physiology; D000067956:Adenylyl Cyclase Inhibitors; D000273:Adipose Tissue / Q000201:enzymology / Q000378:metabolism; D000311:Adrenal Glands / Q000378:metabolism; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D001001:Anura; D000242:Cyclic AMP / Q000502:physiology; D004702:Endocrine Glands / Q000378:metabolism; D004837:Epinephrine / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D050356:Lipid Metabolism; D007986:Luteinizing Hormone / Q000494:pharmacology; D009206:Myocardium / Q000378:metabolism; D009539:Nicotinic Acids / Q000494:pharmacology; D009705:Nucleosides / Q000494:pharmacology; D010744:Phosphoric Monoester Hydrolases / Q000037:antagonists & inhibitors; D011453:Prostaglandins / Q000494:pharmacology; D011817:Rabbits; D012867:Skin / Q000378:metabolism; D014566:Urogenital System / Q000378:metabolism
D000227:Adenine Nucleotides; D000067956:Adenylyl Cyclase Inhibitors; D000319:Adrenergic beta-Antagonists; D007328:Insulin; D009539:Nicotinic Acids; D009705:Nucleosides; D011453:Prostaglandins; D000255:Adenosine Triphosphate; D000324:Adrenocorticotropic Hormone; D007986:Luteinizing Hormone; D000242:Cyclic AMP; D010744:Phosphoric Monoester Hydrolases; D004837:Epinephrine